Bright Minds Biosciences Inc C.DRUG

BMB to participate in the LD Investment Conference

[amichael]

Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (CSE: DRUG) (OTCQB: BMBIF), a biotechnology company focused on developing novel drugs for targeted treatment of neuropsychiatric disorders, epilepsy and pain, today announced that Ian McDonald, Chief Executive Officer of Bright Minds, will present at the LD Micro Main Event Small Cap Investment Conference as follows:

Date: Tuesday, October 12, 2021
Time:12:30PM PT/3:30PM ET
Webcast: https://me21.mysequire.com/

 

Bright Minds’ management team will also be conducting meetings with institutional investors throughout the conference. To schedule a meeting, please visit https://www.meetmax.com/sched/event_76871/conference_home.html

 

An archived replay of the presentation will be available on the Company’s website immediately following the conference and will be available for 90 days at: https://brightmindsbio.com/investors/

 

Source: https://www.globenewswire.com/news-release/2021/10/06/2309406/0/en/Bright-Minds-Biosciences-to-Present-at-the-LD-Micro-Main-Event-Small-Cap-Investment-Conference.html

 

 

 

 

Enable GingerCannot connect to Ginger Check your internet connection
or reload the browserDisable in this text fieldRephraseRephrase current sentenceEdit in Ginger×